Early-Stage Prostate Cancer Workup: Imaging, Genomics, and Patient Health

A regional roundtable discussion, moderated by Gregg Franklin, MD, PhD, New Mexico Cancer Center, explored current and emerging strategies in the management of metastatic castration-sensitive and castration-resistant prostate cancer, including clinical trial data, treatment sequencing, toxicity management, and the future role of targeted therapies and radiopharmaceuticals in patient care. Dr. Franklin was joined by other practitioners in the greater Albuquerque area, including Kathryn Chan, MD, Nexus Health; Laura Onorato, PA, New Mexico Cancer Center; Jose Avitia, MD, New Mexico Cancer Center; and Scott Herbert, MD, Nexus Health. In the first segment, the panel sets the stage for a wide-ranging discussion on evolving treatment strategies for prostate cancer. They explore approaches to early-stage workup, the role of PSMA PET and genomic testing, and the importance of balancing treatment decisions with patient comorbidities and overall health.